Scarica l'app Stockscreener
0.581
2.79%
-0.0167
Dopo l'orario di chiusura:
.61
0.029
+4.99%
Gelteq Ltd Borsa (GELS) Ultime notizie
Gelteq (GELS) wins shareholder approval and closes $2.5M second tranche note - Stock Titan
GELSGelteq Ltd Short Interest - Finviz
Gelteq (GELS) faces $5.3M working capital deficit and rising debt - Stock Titan
Gelteq Company Profile & Introduction - Moomoo
Gelteq Ltd (GELS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Gelteq Ltd (GELS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Gelteq Ltd (GELS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Gelteq Ltd (GELS) Institutional Confidence - TradingKey
Gelteq Ltd (GELS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Gelteq Ltd (GELS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Gelteq advances clinical programs across pharmaceutical and veterinary applications By Investing.com - Investing.com India
Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs - The Manila Times
Gelteq lines up first human trial, vet study and $3.5M financing - Stock Titan
Gelteq Ltd (GELS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Gelteq Ltd (GELS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Gelteq Ltd (GELS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GELS Stock Rockets On Massive Volume As Traders Pile In - StocksToTrade
10 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
$Gelteq (GELS.US)$ thank you - Moomoo
Gelteq Successfully Completes Veterinary Palatability Trials with Kemin, Further Validating Gelteq® Technology for Animal Health Applications - The Manila Times
What's Going On With Gelteq Stock Friday?Gelteq (NASDAQ:GELS) - Benzinga
Dogs accept gels that hide bitter medicine, Gelteq trials show - Stock Titan
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
$Gelteq (GELS.US)$ 👍 sold all already. thank you![Drool][Cool Guy][Rich][Peace][Blessing] - Moomoo
Gelteq establishes Centre of Excellence in China to accelerate product development - BioSpectrum Asia
Gelteq establishes center of excellence in China’s Guangdong By Investing.com - Investing.com South Africa
Gelteq establishes center of excellence in China’s Guangdong - Investing.com
Gelteq Establishes Center of Excellence in China to Accelerate Product Development and Commercial Expansion - The Manila Times
Gelteq sets up Guangdong hub as China biotech deals near $60B - Stock Titan
Gelteq Limited announced that it expects to receive $3.5 million in funding - marketscreener.com
Gelteq (GELS) calls Special Meeting on convertible note share issuance and 9.99% cap - Stock Titan
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities - MSN
Gelteq secures up to $3.5 million in convertible debt financing By Investing.com - Investing.com India
Gelteq secures up to $3.5 million in convertible debt financing - Investing.com
Gelteq (NASDAQ: GELS) inks up to $3.5M structured convertible note deal - Stock Titan
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Gelteq begins clinical trial for veterinary antiparasitic drug - Investing.com
Gelteq begins clinical trial for veterinary antiparasitic drug By Investing.com - Investing.com South Africa
Gelteq Commences Veterinary Medicine Clinical Trial to Support an FDA Regulatory Pathway - The Manila Times
Inside Gelteq’s first vet drug trial in a $78B animal health market - Stock Titan
Gelteq secures up to $3.5M debt financing to support commercialization - MSN
Sommer Ray’s Imaraïs taps Healthy Extracts to make 4M beauty gummies - Stock Titan
TradingKey - TradingKey
Gelteq announces USD $3.5 million strategic debt financing to accelerate commercialization and support revenue growth - marketscreener.com
Gelteq Secures USD $3.5 Million in Debt Financing on May 12, 2026 - geneonline.com
Gelteq secures up to $3.5M debt financing for trials - Investing.com
Gelteq secures up to $3.5M debt financing for trials By Investing.com - Investing.com India
Gelteq Announces USD $3.5 Million Strategic Debt Financing to Accelerate Commercialization and Support Revenue Growth - marketscreener.com
Gelteq lands $3.5M to speed its pharmaceutical and nutraceutical gels - Stock Titan
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner - MSN
What makes Gelteq Limited (GELS) a compelling holding for the long term (Hovering) 2026-05-08Trending Entry Points - Newser
What Gelteq Limited (GELS) is doing that smarter investors notice (Institutional Selling) 2026-05-05Social Buzz - Newser
GELS Price Today: Gelteq Limited Stock Price, Quote & Chart | MEXC - MEXC Exchange
GELS (Gelteq Limited) management prioritizes emerging tech vertical investments to drive future sustainable revenue growth.Expert Momentum Signals - Newser
Simon H Szewach Net Worth (2026) - GuruFocus
Bradley Glenn Karp Net Worth (2026) - GuruFocus
Nathan J Givoni Net Worth (2026) - GuruFocus
0.15%
1.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):